BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07652242-completion@plaintrial.com
DTSTAMP:20261028T171444Z
DTSTART;VALUE=DATE:202808
SUMMARY:First-in-human\, Phase 1 Study of a Self-amplifying RNA Vaccine (IT
 I-5000) Alone or in Combination With Pembrolizumab in Stage II-- III Tripl
 e Negative Breast Cancer Following Standard Therapy ( VITAL-TNBC ) — est
 imated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT07652242
URL:https://plaintrial.com/trial/NCT07652242
END:VEVENT
END:VCALENDAR